Solitary fibular metastasis from nonsmall cell lung carcinoma

Akram, Mohammad; Zaheer, Sufian; Hussain, Asif; Siddiqui, Shahid Ali; Afrose, Ruquiya; Khalid, Saifullah

doi:10.4103/0970-9371.203577

Cited by 4 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…MBD of the tibia has been reported to account for 3%-4% of MBD, thus being more frequent than metastases in the foot[ 17 , 40 ]. Fibular metastases are very rare and the representation in the literature mainly consists of case reports[ 41 - 43 ]. Due to its rarity, published cohorts of cases are small[ 17 , 44 ] .…”

Section: Acrometastases Of Lower Extremitymentioning

confidence: 99%

Surgical treatment of metastatic bone disease of the distal extremities

Sebghati¹,

Khalili²,

Tsagozis³

2021

WJO

View full text Add to dashboard Cite

Metastatic bone disease of the distal extremities, also known as acrometastasis, is very rare. Thus, there is very limited information regarding the clinical manifestations and methods of surgical treatment. The current available literature shows that acrometastases are often encountered in the context of advanced disease and are thus associated with poor patient survival. As metastatic bone disease is generally uncurable, the goal of surgical treatment is to provide the patient with good function with as few complications as possible. In this article, we discuss the clinical manifestation of acrometastases, the methods of surgical intervention, and the expected clinical outcome. Non-surgically managed pathological fractures generally remain ununited; therefore, conservative treatment is reserved for patients with poor general condition or dismal prognosis. The current evidence suggests that in lesions of the lower arm and leg, osteosynthesis (plate and screw fixation or intramedullary nail) is the most common method of reconstruction, whereas local excision or amputation are more commonly used in cases of more distal lesions (such as ankle, foot and hand). Following surgery most patients receive adjuvant radiotherapy, even though its role is poorly documented. Close collaboration between orthopedic surgeons and medical oncologists is necessary to improve patient care and treatment outcome. Further studies are needed in order to provide stronger clinical evidence and improve decision-making, in an effort to optimize the patients’ quality of life and avoid the need for revision surgery.

show abstract

Section: Acrometastases Of Lower Extremitymentioning

confidence: 99%

Surgical treatment of metastatic bone disease of the distal extremities

Sebghati¹,

Khalili²,

Tsagozis³

2021

WJO

View full text Add to dashboard Cite

show abstract

Management of Lung Cancer Presenting with Solitary Bone Metastasis

Nistor¹,

Ciuche²,

Cucu³

et al. 2022

Medicina

View full text Add to dashboard Cite

Lung neoplasm is the main cause of cancer-related mortality, and bone metastasis is among the most common secondary tumors. The vast majority of patients also present with multiple bone metastases, which makes systemic and adjuvant pain therapy preferable to surgery. The optimal approach for a resectable non-small-cell lung tumor that also presents a unique, resectable bone metastasis is not fully established. The number of papers addressing this subject is small, and most are case reports; nevertheless, survival rates seem to increase with radical surgery. The sequencing of local versus systemic treatment should always be discussed within the multidisciplinary team that will choose the best approach for each patient. As targeted systemic therapies become more accessible, radical surgery, together with existing reconstructive methods, will lead to an increase in life expectancy and a better quality of life.

show abstract